Skip to content
Monoamine Oxidase Inhibitor (MAOI)

Phenelzine

Phenelzine is a potent, non-selective monoamine oxidase inhibitor (MAOI) indicated for the treatment of atypical depression, particularly in patients who have not responded to other antidepressants. It is also effective for certain anxiety disorders, including social anxiety disorder and panic disorder with agoraphobia.

Clinical Overview

Primary Clinical Applications

Phenelzine is indicated for depression that is characterized as atypical, nonendogenous, or neurotic, particularly when patients have not responded to tricyclic antidepressants or other therapies. It shows particular efficacy in depression with anxiety, phobic symptoms, or hypochondriasis.

Mechanism and Clinical Considerations

By irreversibly inhibiting both MAO-A and MAO-B enzymes, phenelzine increases levels of norepinephrine, serotonin, and dopamine. This broad mechanism provides antidepressant and anxiolytic effects but requires strict dietary restrictions and careful drug interaction monitoring.

Specialized Usage Requirements

Due to potentially life-threatening interactions with tyramine-containing foods and numerous medications, phenelzine requires extensive patient education, dietary counseling, and careful monitoring. It is typically reserved for treatment-resistant cases.

Key Clinical Points

Washout of two to five weeks from an SSRI

Longer than the standard fourteen days where the previous drug was fluoxetine, because of norfluoxetine's persistence. Getting this wrong risks serotonin syndrome.

Strict tyramine restriction

Aged cheeses, cured meats, fermented products, broad beans, soy sauce, yeast extracts, and alcoholic beverages including Chianti. Dietary counselling is a prerequisite, not a follow-up item.

Broad cardiovascular contraindications

Congestive heart failure, cardiovascular and cerebrovascular disease, hypertension, phaeochromocytoma, liver disease, and severe renal impairment all rule it out. A history of headache is also listed.

Particular efficacy in atypical depression

Depression with anxiety, phobic symptoms, or hypochondriasis responds notably well, which is why phenelzine retains a place despite the burden of restrictions.

Stop ten days before elective surgery

Interactions with general anaesthetics are dangerous. Meperidine and dextromethorphan are contraindicated outright, and orthostatic hypotension is the most common day-to-day effect.

Prescribing Information

Dosing & Administration

Depression:

  • Initial: 15 mg three times daily
  • Increase: To 60 mg daily fairly rapidly as tolerated
  • Maximum: 90 mg daily
  • Maintenance: Reduce to lowest effective dose after response

Elderly:

  • Start with lower doses (15 mg daily)
  • Increase more gradually

Indications

  • Atypical depression
  • Depression unresponsive to other treatments
  • Off-label: Social anxiety disorder, panic disorder

Contraindications

  • Congestive heart failure
  • Pheochromocytoma
  • Liver disease or abnormal liver function
  • Severe renal impairment
  • Cerebrovascular disease
  • Cardiovascular disease
  • Hypertension
  • History of headache

Warnings & Precautions

  • Hypertensive crisis: Avoid tyramine-containing foods
  • Serotonin syndrome: Contraindicated with SSRIs, SNRIs
  • Suicidal thoughts: Monitor especially in young adults
  • Orthostatic hypotension: Common side effect
  • Withdrawal: Discontinue gradually

Drug Interactions

  • SSRIs/SNRIs: Contraindicated – 2-5 week washout required
  • Sympathomimetics: Risk of hypertensive crisis
  • Meperidine: Contraindicated – risk of serotonin syndrome
  • Dextromethorphan: Contraindicated
  • General anesthetics: Discontinue 10 days before surgery

Dietary Restrictions

  • High tyramine foods: Aged cheeses, cured meats, fermented products
  • Alcoholic beverages: Beer, wine, especially Chianti
  • Other: Broad beans, soy sauce, yeast extracts

Adverse Reactions

Common:

  • Orthostatic hypotension, dizziness, headache, drowsiness

Serious:

  • Hypertensive crisis, serotonin syndrome, hepatotoxicity

Special Populations

  • Pregnancy: Category C – use only if clearly needed
  • Elderly: Increased sensitivity to hypotensive effects
  • Hepatic impairment: Contraindicated

Frequently Asked Questions

What is Phenelzine used for?

Phenelzine is a potent, non-selective monoamine oxidase inhibitor (MAOI) indicated for the treatment of atypical depression, particularly in patients who have not responded to other antidepressants. It is also effective for certain anxiety disorders, including social anxiety disorder and panic disorder with agoraphobia.

What class of drug is Phenelzine?

Phenelzine is classified as: Monoamine Oxidase Inhibitor (MAOI).

Washout of two to five weeks from an SSRI?

Longer than the standard fourteen days where the previous drug was fluoxetine, because of norfluoxetine's persistence. Getting this wrong risks serotonin syndrome.

Strict tyramine restriction?

Aged cheeses, cured meats, fermented products, broad beans, soy sauce, yeast extracts, and alcoholic beverages including Chianti. Dietary counselling is a prerequisite, not a follow-up item.

Broad cardiovascular contraindications?

Congestive heart failure, cardiovascular and cerebrovascular disease, hypertension, phaeochromocytoma, liver disease, and severe renal impairment all rule it out. A history of headache is also listed.

Particular efficacy in atypical depression?

Depression with anxiety, phobic symptoms, or hypochondriasis responds notably well, which is why phenelzine retains a place despite the burden of restrictions.

Source: FDA prescribing information (DailyMed)

Medical Disclaimer: This information is for educational purposes only and is not intended as medical advice. Always consult with qualified healthcare professionals before making any treatment decisions. Individual patient circumstances may vary significantly.